Literature DB >> 10053201

Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules.

L Erlich1, D Yu, D A Pallister, R S Levinson, D G Gole, P A Wilkinson, R E Erlich, L E Reeve, T X Viegas.   

Abstract

Danazol was dissolved in non-aqueous mixtures containing either polyethylene glycol 400 or polysorbate 80, and filled into hard gelatin capsules at 50 mg concentrations. The bioavailability of these formulations was compared with commercial danazol capsules in a two-way crossover study using young female beagle dogs. Both formulations showed greater oral bioavailability when compared with either the 100 or 200 mg commercial brand of danazol. The bioavailability of the polyethylene glycol 400 and polysorbate 80 formulations was enhanced 3.7 and 15.8 times, respectively, when compared at the 100 mg dose level. Copyright.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10053201     DOI: 10.1016/s0378-5173(98)00386-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

2.  Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2018-02-02       Impact factor: 4.200

3.  Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.

Authors:  Matthew J Jackson; Umesh S Kestur; Munir A Hussain; Lynne S Taylor
Journal:  Pharm Res       Date:  2016-02-18       Impact factor: 4.200

4.  Glyceride lipid formulations: molecular dynamics modeling of phase behavior during dispersion and molecular interactions between drugs and excipients.

Authors:  Dallas B Warren; Dylan King; Hassan Benameur; Colin W Pouton; David K Chalmers
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

Review 5.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Ben J Boyd; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

7.  Evaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs.

Authors:  Harikrishna Devalapally; Svitlana Silchenko; Feng Zhou; Jessica McDade; Galina Goloverda; Albert Owen; Ismael J Hidalgo
Journal:  J Pharm Sci       Date:  2013-07-22       Impact factor: 3.534

8.  Non-linear increases in danazol exposure with dose in older vs. younger beagle dogs: the potential role of differences in bile salt concentration, thermodynamic activity, and formulation digestion.

Authors:  Mette U Anby; Hywel D Williams; Orlagh Feeney; Glenn A Edwards; Hassan Benameur; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2014-01-30       Impact factor: 4.200

Review 9.  Challenges of Dissolution Methods Development for Soft Gelatin Capsules.

Authors:  Festo Damian; Mohammad Harati; Jeff Schwartzenhauer; Owen Van Cauwenberghe; Shawn D Wettig
Journal:  Pharmaceutics       Date:  2021-02-04       Impact factor: 6.321

10.  Prediction of aqueous intrinsic solubility of druglike molecules using Random Forest regression trained with Wiki-pS0 database.

Authors:  Alex Avdeef
Journal:  ADMET DMPK       Date:  2020-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.